Search results
- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, November 12, 2024, at 8:00 a.m. ET to report third quarter 2024 financial results and discuss recent business highlights.
People also ask
Does Heron therapeutics have a conference call?
Does Heron therapeutics have a new drug application for zynrelef?
What is the 12-month price forecast for heron Therapeutics (hrtx)?
Who is Heron Therapeutics?
How did Heron Therapeutics perform in 2023?
Who owns Heron Therapeutics stock?
3 days ago · Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on ...
- Q3 2023 Heron Therapeutics Inc Earnings Call - Yahoo Finance
For those of you participating via conference call, slides...
- Q3 2023 Heron Therapeutics Inc Earnings Call - Yahoo Finance
May 15, 2024 · 08/06/2024 at 4:30 pm EDT. Heron Therapeutics Q2 2024 Conference Call. Click here for webcast. 05/15/2024 at 9:30 am EDT. Heron Therapeutics Investor Day.
4 days ago · SAN DIEGO, Oct. 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, November 12, 2024, at 8:00 a.m. ET to report third quarter 2024 financial results and discuss recent business highlights.
May 15, 2024 · Receive news and updates on Heron’s latest innovations. The Investor Relations website contains information about Heron Therapeutics's business for stockholders, potential investors, and financial analysts.
Aug 9, 2024 · Thank you for joining us on the Heron Therapeutics conference call this afternoon to discuss the company's financial results for the quarter ended June 30, 2024.
Oct 25, 2024 · Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secr...
For those of you participating via conference call, slides are made available via webcast. It can also be accessed via the Investor Relations page of our website following the conclusion of...